000 01502 a2200421 4500
005 20250514015300.0
264 0 _c20011213
008 200112s 0 0 eng d
022 _a0021-972X
024 7 _a10.1210/jcem.86.11.8030
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlzahrani, A S
245 0 0 _a123I isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer: comparison with post 131I therapy whole body scanning.
_h[electronic resource]
260 _bThe Journal of clinical endocrinology and metabolism
_cNov 2001
300 _a5294-300 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIodine Radioisotopes
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRadionuclide Imaging
650 0 4 _aRadiopharmaceuticals
_xtherapeutic use
650 0 4 _aThyroglobulin
_xmetabolism
650 0 4 _aThyroid Neoplasms
_xdiagnostic imaging
650 0 4 _aWhole-Body Counting
700 1 _aBakheet, S
700 1 _aAl Mandil, M
700 1 _aAl-Hajjaj, A
700 1 _aAlmahfouz, A
700 1 _aAl Haj, A
773 0 _tThe Journal of clinical endocrinology and metabolism
_gvol. 86
_gno. 11
_gp. 5294-300
856 4 0 _uhttps://doi.org/10.1210/jcem.86.11.8030
_zAvailable from publisher's website
999 _c11616964
_d11616964